rs8178561

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000628.5(IL10RB):​c.*135G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0582 in 850,424 control chromosomes in the GnomAD database, including 1,893 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.079 ( 642 hom., cov: 32)
Exomes 𝑓: 0.054 ( 1251 hom. )

Consequence

IL10RB
NM_000628.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.190

Publications

8 publications found
Variant links:
Genes affected
IL10RB (HGNC:5965): (interleukin 10 receptor subunit beta) The protein encoded by this gene belongs to the cytokine receptor family. It is an accessory chain essential for the active interleukin 10 receptor complex. Coexpression of this and IL10RA proteins has been shown to be required for IL10-induced signal transduction. This gene and three other interferon receptor genes, IFAR2, IFNAR1, and IFNGR2, form a class II cytokine receptor gene cluster located in a small region on chromosome 21. [provided by RefSeq, Jul 2008]
IL10RB Gene-Disease associations (from GenCC):
  • inflammatory bowel disease 25
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • IL10-related early-onset inflammatory bowel disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 21-33296492-G-A is Benign according to our data. Variant chr21-33296492-G-A is described in ClinVar as Benign. ClinVar VariationId is 339699.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.138 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL10RBNM_000628.5 linkc.*135G>A 3_prime_UTR_variant Exon 7 of 7 ENST00000290200.7 NP_000619.3 Q08334

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL10RBENST00000290200.7 linkc.*135G>A 3_prime_UTR_variant Exon 7 of 7 1 NM_000628.5 ENSP00000290200.2 Q08334
IFNAR2-IL10RBENST00000433395.7 linkc.*135G>A 3_prime_UTR_variant Exon 13 of 13 5 ENSP00000388223.3 H0Y3Z8

Frequencies

GnomAD3 genomes
AF:
0.0788
AC:
11982
AN:
152092
Hom.:
635
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.141
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.0576
Gnomad ASJ
AF:
0.0868
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00911
Gnomad FIN
AF:
0.0538
Gnomad MID
AF:
0.0886
Gnomad NFE
AF:
0.0609
Gnomad OTH
AF:
0.0746
GnomAD2 exomes
AF:
0.0483
AC:
6733
AN:
139398
AF XY:
0.0452
show subpopulations
Gnomad AFR exome
AF:
0.147
Gnomad AMR exome
AF:
0.0369
Gnomad ASJ exome
AF:
0.0896
Gnomad EAS exome
AF:
0.00115
Gnomad FIN exome
AF:
0.0510
Gnomad NFE exome
AF:
0.0597
Gnomad OTH exome
AF:
0.0561
GnomAD4 exome
AF:
0.0536
AC:
37454
AN:
698214
Hom.:
1251
Cov.:
9
AF XY:
0.0508
AC XY:
18776
AN XY:
369298
show subpopulations
African (AFR)
AF:
0.142
AC:
2627
AN:
18524
American (AMR)
AF:
0.0382
AC:
1336
AN:
35012
Ashkenazi Jewish (ASJ)
AF:
0.0903
AC:
1889
AN:
20928
East Asian (EAS)
AF:
0.000579
AC:
19
AN:
32792
South Asian (SAS)
AF:
0.0118
AC:
782
AN:
66132
European-Finnish (FIN)
AF:
0.0479
AC:
1644
AN:
34292
Middle Eastern (MID)
AF:
0.0634
AC:
276
AN:
4350
European-Non Finnish (NFE)
AF:
0.0589
AC:
26575
AN:
450816
Other (OTH)
AF:
0.0652
AC:
2306
AN:
35368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1631
3262
4893
6524
8155
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
520
1040
1560
2080
2600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0789
AC:
12015
AN:
152210
Hom.:
642
Cov.:
32
AF XY:
0.0776
AC XY:
5772
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.141
AC:
5866
AN:
41514
American (AMR)
AF:
0.0575
AC:
879
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0868
AC:
301
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00891
AC:
43
AN:
4826
European-Finnish (FIN)
AF:
0.0538
AC:
570
AN:
10592
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.0609
AC:
4141
AN:
68018
Other (OTH)
AF:
0.0771
AC:
163
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
542
1084
1626
2168
2710
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0720
Hom.:
744
Bravo
AF:
0.0816
Asia WGS
AF:
0.0360
AC:
125
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inflammatory bowel disease 25 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.8
DANN
Benign
0.28
PhyloP100
-0.19
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8178561; hg19: chr21-34668797; API